For Murad Acne Complex Ads, ERSP Draws Line Between "Clear" And "Clears"
This article was originally published in The Tan Sheet
Executive Summary
Murad should change the "Get Clear In Four Weeks” claim for Murad Acne Complex to align more closely with FDA’s language and intent in the OTC acne product monograph, according to an industry self-regulation group.
You may also be interested in...
Stiefel's MaxClarity "More Medicine," Severe Acne Claims Irritate Competitor
Stiefel Laboratories' claims suggesting its MaxClarity foam-based system can treat severe acne by delivering more medicine than alternative products and without irritation did not sit well with the competition
Murad Implied Claims Should Be Modified While Acne Claims Are Supported
Murad should not imply Acne Skin Complex treats all causes of skin breakouts in direct advertising, according to the Council of Better Business Bureaus' Electronic Retailing Self-Regulation Program. ERSP issued the recommendation Feb. 16 on the National Advertising Review Council Web site after reviewing a 30-minute infomercial for the anti-acne system
J&J Consumer Sales Slip Even As Recalled Brands, Seasonal Items Reach Stores
J&J reports worldwide consumer sales dipped 0.6% to $3.6 billion despite retailers buying more upper respiratory and analgesic products to prepare for the cough and cold season. But in key OTC categories the firm is regaining market share it lost when its iconic brands were temporarily not available.